Evidence map›Paper›PMID 40536274›Full record

Observational studyMycoses2025

Risk Factors and Long-Term Prognosis for Coinfection of Nontuberculous Mycobacterial Pulmonary Disease and Chronic Pulmonary Aspergillosis: A Multicentre Observational Study in Japan.

Yasuhiro Tanaka, Shotaro Ide, Takahiro Takazono, Kazuaki Takeda, Naoki Iwanaga, Masataka Yoshida, Naoki Hosogaya, Yusei Tsukamoto, Satoshi Irifune, Takayuki Suyama and 18 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Mycoses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Immune interaction betweenFrontiers in cellular and infection microbiology · 2026
    Article
  5. Observational
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Yasuhiro TanakaDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.ORCID https://orcid.org/0009-0009-7713-9047
Shotaro IdeInfectious Diseases Experts Training Center, Nagasaki University Hospital, Nagasaki, Japan.ORCID https://orcid.org/0000-0001-7872-8147
Takahiro TakazonoDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.ORCID https://orcid.org/0000-0002-0696-5386
Kazuaki TakedaDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.ORCID https://orcid.org/0000-0003-1611-4435
Naoki IwanagaDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.ORCID https://orcid.org/0000-0002-0680-390X
Masataka YoshidaDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.ORCID https://orcid.org/0009-0001-2955-6825
Naoki HosogayaClinical Research Center, Nagasaki University Hospital, Nagasaki, Japan.ORCID https://orcid.org/0000-0002-3229-2277
Yusei TsukamotoDepartment of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Satoshi IrifuneDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.ORCID https://orcid.org/0000-0001-5689-0418
Takayuki SuyamaDepartment of Respiratory Medicine, Nagasaki Gotochuoh Hospital, Goto, Japan.
Tomo MiharaDepartment of Respiratory Medicine, Japan Community Health Care Organization Isahaya General Hospital, Isahaya, Japan.
Akira KondoDepartment of Respiratory Medicine, NHO Nagasaki Medical Center, Omura, Japan.
Tsutomu KobayashiDepartment of Respiratory Medicine, Sasebo Chuo Hospital, Sasebo, Japan.
Yuichi FukudaDepartment of Respiratory Medicine, Sasebo City General Hospital, Sasebo, Japan.
Eisuke SasakiDepartment of Respiratory Medicine, NHO Ureshino Medical Center, Ureshino, Japan.
Toyomitsu SawaiDepartment of Respiratory Medicine, Nagasaki Harbor Medical Center, Nagasaki, Japan.ORCID https://orcid.org/0000-0002-1263-1243
Yasuhito HigashiyamaDepartment of Internal Medicine, Hokusho Central Hospital, Sasebo, Japan.
Kohji HashiguchiDepartment of Respiratory Medicine, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
Minako HanakaRespiratory Medicine, Iizuka Hospital, Iizuka, Japan.
Toshihiko IiDepartment of Respiratory Medicine, NHO Miyazaki Higashi Hospital, Miyazaki, Japan.
Kiyoyasu FukushimaDepartment of Respiratory Medicine, Japanese Red Cross Nagasaki Genbaku Isahaya Hospital, Isahaya, Japan.ORCID https://orcid.org/0000-0002-1833-7723
Kosaku KomiyaRespiratory Medicine and Infectious Diseases, Oita University Faculty of Medicine, Yufu, Japan.ORCID https://orcid.org/0000-0002-8679-1661
Taiga MiyazakiDivision of Respirology, Rheumatology, Infectious Diseases and Neurology, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan.ORCID https://orcid.org/0000-0002-0962-5758
Kazuhiro YateraDepartment of Respiratory Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.ORCID https://orcid.org/0000-0002-2955-4432
Koichi IzumikawaDepartment of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Akitsugu FurumotoInfectious Diseases Experts Training Center, Nagasaki University Hospital, Nagasaki, Japan.
Katsunori YanagiharaDepartment of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Hiroshi MukaeDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.ORCID https://orcid.org/0000-0002-1429-5706

Funding

Non-profit Organization Aimed to Support Community Medicine Research in Nagasaki 3612Research Center for GLOBAL and LOCAL Infectious Diseases, Oita University 2023B15
6 · The paper itself

Abstract

backgroundNontuberculous mycobacterial pulmonary disease (NTM-PD) is a chronic respiratory infection with increasing prevalence and mortality worldwide. Coinfection with chronic pulmonary aspergillosis (CPA) is a significant complication of NTM-PD, often complicating treatment and resulting in poor prognosis.

objectiveIn this multicentre, retrospective cohort study, we examined the epidemiology, comorbidities, risk factors for CPA coinfection and long-term prognosis of patients with NTM-PD infected with CPA in Japan.

methodsPatients aged ≥ 18 years with newly diagnosed NTM-PD who visited 18 hospitals between 2010 and 2017 in Kyushu, Japan, were included. Medical records were reviewed for patient characteristics, mycobacterial species, laboratory data, radiological features, Aspergillus coinfection and all-cause mortality rates. Risk factors for CPA coinfection were analysed using multiple logistic regression, and survival analysis was performed before and after propensity score matching with risk factors.

resultsAmong 1304 patients with NTM-PD, 45 (3.5%) were diagnosed with CPA, including 42 with chronic progressive pulmonary aspergillosis. The risk factors for CPA coinfection included male sex, chronic obstructive pulmonary disease, oral corticosteroid use and cavity formation. All-cause mortality was significantly higher in patients with NTM-PD with CPA than in those without CPA (log-rank test, p < 0.001; crude hazard ratio [HR], 3.98). Survival analysis after propensity score matching suggested CPA was an independent poor prognostic factor (log-rank test, p = 0.036; adjusted HR, 1.59).

conclusionCPA is an independent poor prognostic factor in patients with NTM-PD. Clinicians must consider CPA when treating patients with NTM-PD, particularly those with high-risk factors, to ensure timely diagnosis and management.

Indexed as

CoinfectionMycobacterium Infections, NontuberculousPulmonary AspergillosisAdultAgedAged, 80 and overChronic DiseaseFemaleHumansJapanMaleMiddle AgedPrognosisRetrospective StudiesRisk FactorsAspergilluscoinfectionMycobacterium avium complexMycobacterium infectionsnontuberculous mycobacteriapropensity scorepulmonary aspergillosisretrospective studies

Identifiers

PMID40536274
PMCPMC12178108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.